cryptocurrency and its future, Featured snippets

Market news: South Korean prosecutors approved the postponement of the execution of the ruling request of Cao Guo, the leader of the opposition motherland reform party.Market News: Lotte Chemical will suspend the Johor plant to reduce losses.Spot gold fell below $2,680 per ounce, down 1.38% in the day. COMEX gold futures fell 2.00% in the day and are now reported at $2701.50 per ounce.

Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.Dongfang Zhizao recorded 7 boards in 9 days, and Dongfang Zhizao recorded 7 daily limit again, with a cumulative increase of 73.59% and a cumulative turnover rate of 262.35%. As of 14:05, the stock traded 353 million shares today, with a turnover of 2.753 billion yuan and a turnover rate of 27.62%. The total market value of the latest A shares reached 10.24 billion yuan, and the circulating market value of A shares was 10.24 billion yuan.A number of officials from Turkey and Qatar will visit Syria to meet with the Syrian transitional government. On the 12th local time, the Syrian Ministry of Information announced that the Turkish Foreign Minister, the head of the intelligence department and the head of Qatar's national security department will visit Syria and meet with the leader of the Sharm el-Liberation Organization, Giulani, and the caretaker Prime Minister of the Syrian transitional government, Bashir. Up to now, Turkish and Qatar officials have not announced relevant news.

The Kuala Lumpur Composite Index of Malaysia closed up 0.4% at 1,608.75.BOC International: Reiterating that China Telecom is the first choice for the "buy" rating of Chinese telecom stocks, BOC International published a research report that the contribution of cloud services to revenue and profit continues to promote the growth of Chinese telecom operators, and cloud and artificial intelligence services are becoming the only sustainable driving force for Chinese telecom operators' revenue and EBITDA. China Telecom and China Unicom have recorded steady growth in profit margin of EBITDA in two quarters this year. With the development of state-owned enterprises and local governments, the bank expects to support the development of end-to-end proprietary cloud infrastructure services for telecom operators for a long time to improve security and regulatory requirements, and at the same time, Chinese telecom stocks can provide attractive valuation and dividend returns to support their long-term performance. Therefore, it reiterates its "buy" rating for Chinese telecom stocks, with China Telecom as the first choice, followed by China Unicom and China Mobile.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.